Lord Freyberg – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Lord Freyberg on 2016-01-21.
To ask Her Majesty’s Government whether the cancer panel test used at the main NHS tertiary hospitals will provide the vast majority of clinically actionable information in a tumour genome, in the light of the NHS reimbursement environment for targeted therapies.
Lord Prior of Brampton
A range of cancer panel tests are undertaken by National Health Service trusts. Whether or not these tests capture the majority of clinically actionable information in the tumour genome will not be known until the outcomes from the cancer element of the 100,000 Genomes Project is known.
